 TORRANCE, Calif., Aug. 2, 2021 PRNewswire -- Emmaus Life Sciences, Inc. OTC: EMMA, a leader in the treatment of sickle cell disease, announced today that Endari has been included on the Preferred Drug List published on July 29, 2021, by Texas Health and Human Services THHS. 